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Abstract: Six new (3Z,5E)-11,20-epoxybriara-3,5-dien-7,18-olide diterpenoids, 
gemmacolides N–S (1–6), were isolated together with four known analogues, 
juncenolide D, and juncins R, S and U (7–10), from the South China Sea gorgonian 
Dichotella gemmacea. The structures of the new compounds were elucidated by the 
detailed analysis of spectroscopic data in combination with the comparison with reported 
data. The absolute configuration of 1 was determined by a TDDFT calculation of its 
solution ECD spectrum, affording the determination of absolute configuration of other 
analogues by simply comparing their ECD spectra with that of 1. The cytotoxic and 
antimicrobial activities of these compounds were evaluated. In preliminary in vitro 
bioassays, compounds 4, 5, 6, 8 and 9 showed cytotoxicity against A549 and MG63, while 
compounds 1, 2, 4, 7–10 showed antimicrobial activity against the fungus Septoria tritici 
and the bacterium Escherichia coli. 
Keywords: briarane diterpenoids; biological activity; structure elucidation; gorgonian; 
Dichotella gemmacea 
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1. Introduction  
Briarane-type diterpenoids are a group of highly oxidized secondary metabolites reported from 
marine organisms, particularly from octocorals [1]. These kinds of molecules are derived from 
cembrane diterpenoids by 3,8-cyclization, constructing of a fused six- and 10-membered bicyclic 
carbon skeleton, and also display an additional γ-lactone ring fused with the 10-membered ring [2]. 
The first example of such kind of metabolites, briarein A, was isolated from the Caribbean octocoral 
Briareum asbestinum in 1977 [3]. Since then, a series of briarane diterpenoids have been continuously 
reported in an increasing number due to the structural complexity and interesting biological activities, 
such as cytotoxic [4–8], anti-inflammatory [9–11], antiviral [9,12,13], antifouling [14,15], 
insecticidal [16,17], and immunomodulatory effects [18]. Briarane diterpenoids with the chemical 
feature of 11,20-epoxy-3,5(6)-diene moiety have only been reported so far from two species of 
gorgonian of the family Ellisellidae, i.e., Junceella gemmacea (Dichotella gemmacea) [19] collected 
from Pohnpei of Micronesia [20], and Junceella juncea collected from Tuticorin [21] and the South 
China Sea [14,22]. Some of these compounds exhibited weak cytotoxicity against human liver 
carcinoma (HEPA 59T/VGH) and oral epidermoid (KB) carcinoma cell lines [23] and, in addition, 
antifouling activities against the larval settlement of barnacle Balanus amphitrite [14]. However, the 
absolute configurations of these compounds have not been determined yet, due to the flexibility of the 
10-membered ring and the complexity of the molecules. 
In the course of our ongoing screening for biologically active secondary metabolites from marine 
sources [24–27], we made a collection of the gorgonian Dichotella gemmacea off the coast of Beihai, 
China. The species of D. gemmacea was identified previously as J. gemmacea [19]. Early chemical 
studies on the species resulted in the isolation and characterization of 18 briarane diterpenoids, 
including gemmacolides A–F [20], dichotellides A–E, praelolide, juncin P, juncin ZI, junceellin A [28], 
and three unnamed analogues [29]. Preliminary investigation of the crude extract of D. gemmacea in 
our laboratory led to the isolation and structural determination of seven new bioactive diterpenoids, 
namely gemmacolides G–M [30]. Our continuous investigation on the trace compounds of the crude 
extract has now resulted in the isolation of additional six new members of this family, namely 
gemmacolides N–S (1–6), together with four known analogues, juncenolide D (7) [23], and juncins R, 
S and U (8–10) [14] (Chart 1). Structures of the new compounds were elucidated by detailed analysis 
of their spectroscopic data aided by the comparison with reported data of related derivatives. The 
absolute configuration of 1 was determined by time-dependent density functional theory 
electroniccircular dichroism (TDDFT ECD) calculation of the computed solution conformers. This 
method allowed for the configurational assignment of additional five new and four known analogues. 
Gemmacolide N (1) was chosen as an ECD reference in the determination of absolute configuration for 
this group of metabolites. 
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Chart 1. Structures of compounds 1–10. 
 
R 
Compound 1(C2) 2(C12) 3(C13) 4(C14) 5(C16) 
Gemmacolide N (1) OAc OAc H OAc OCH3 
Gemmacolide O (2) OCOCH2OH OAc OAc OAc Cl 
Gemmacolide P (3) OAc iVal OAc OAc OH 
Gemmacolide Q (4) OCOCH2OH iVal OAc OAc OH 
Gemmacolide R (5) OCOCH2OH OAc OAc iVal OH 
Gemmacolide S (6) OCOCH2OiVal OAc iVal OAc iVal 
Juncenolide D (7) OAc OAc OAc OAc OCH3 
Juncin R (8) OAc OAc OAc iVal Cl 
Juncin S (9) OAc iVal OAc OAc Cl 
Juncin U (10) OAc OAc iVal OAc OCH3 
2. Results and Discussion 
Freshly collected specimens of D. gemmacea were immediately frozen to −20 °C and stored at this 
temperature before extraction. The EtOAc-soluble portion of the combined extracts of acetone and 
methanol was subsequently partitioned between MeOH and n-hexane. The MeOH extract was 
subjected to sequential column chromatography on silicagel, Sephadex LH-20, and the RP-HPLC to 
afford 10 diterpenoids (1–10). The structures and relative stereochemistry of the known  
compounds 7–10 were determined by extensive spectroscopic analysis combined with careful 
comparison with reported data. Juncenolide D (7) was once reported from the Taiwanese gorgonian 
Junceella juncea with its structure being elucidated on the basis of FABMS, UV, IR and NMR 
techniques [23]. Structures of juncins R (8), S (9) and U (10), previously obtained from the South 
China Sea gorgonian Junceella juncea, were also established by extensive spectroscopic analysis [14]. 
The absolute configuration, however, of 7–10 remained unsolved. 
Gemmacolide N (1) was isolated as a white amorphous powder (1.1 mg). Its molecular formula was 
established as C29H38O13 by HRESI-MS, indicating 11 degrees of double bond equivalence. The IR 
spectrum showed absorption bands of hydroxyl (3475 cm−1), a γ-lactone (1776 cm−1), and ester  
(1739 cm−1) functionalities. This observation was in agreement with the signals in the 13C NMR and 
DEPT spectra (Table 1) for nine sp2 carbon atoms (5× OC=O, CH=CH, CH=C) at lower field 
(accounting for seven double bond equivalents) and twenty sp3 carbon atoms at higher field (1× C,  
2× CH, 1× CH2, 6× CH3, 2× OC, 5× OCH, 2× OCH2, 1× OCH3). The remaining double bond 
equivalents were due to the presence of four rings in the molecule. 
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1H and 13C NMR spectra of 1 showed great similarity to those of juncenolide D (7) [23], except that 
one of the acetoxy groups in 7 (δH 1.96, s; δC 169.6, s, 20.5, q; see Experimental) was replaced by a 
hydrogen in 1. This proton was assigned as part of CH2-13 (δH 2.31, 1.92, each, ov., δC 28.5, t; 
Tables 1 and 2) due to the proton sequence of H-12/H2-13/H-14, established by the 1H-1H COSY 
experiment (Figure 1). The established planar structure of 1 was further supported by the 1H-1H COSY 
and HMBC spectra as shown in Figure 1. The relative configuration of 1 at the chiral centers was 
proved the same as that of 7 by a NOESY experiment (Figure 2), showing a β configuration of H-7,  
H-12, H-14, Me-15, H-17, and CH2-20, and a α configuration of H-2, H-9, H-10, and Me-19. The 
geometry of the Δ3 double bond was assigned as (Z) based on the proton coupling constant between  
H-3 and H-4 (J = 10.7 Hz) while that of Δ5 was determined as (E) due to the NOESY correlation 
between H-6 and H2-16. Assignments of NMR signals for structure of 1 were strongly supported by 
comparison with the reported data of frajunolide D, an analogue isolated from the gorgonian 
Junceella fragilis [31]. Frajunolide D differs from 1 only in the functional group at C-16, having an 
acetoxy group instead of a methoxy group. The relative stereochemistry of 1 was thus determined as 
(1R*,2S*,7S*,8S*,9S*,10S*,11R*,12R*,14S*,17R*). 
Table 1. 13C NMR data of gemmacolides N–S (1–6) a. 
Carbon 1 2 3 4 5 6 
1 47.1 s 46.5 s 46.5 s 46.6 s 46.6 s 46.4 s 
2 74.3 d 75.2 d 75.6 d 77.2 d 76.7 d 75.5 d 
3 131.6 d 131.1 d 131.2 d 130.7 d 130.6 d 131.4 d 
4 128.3 d 129.1 d 129.6 d 130.1 d 130.1 d 128.5 d 
5 141.8 s 139.7 s 144.7 s 144.2 s 144.3 s 139.7 s 
6 122.4 d 126.3 d 123.7 d 123.9 d 123.6 d 122.4 d 
7 79.0 d 78.5 d 78.7 d 78.7 d 78.3 d 78.6 d 
8 81.1 s 81.0 s 81.0 s 80.1 s 80.1 s 81.1 s 
9 64.0 d 63.6 d 63.8 d 63.8 d 63.8 d 63.8 d 
10 32.8 d 32.6 d 32.8 d 32.7 d 32.6 d 32.6 d 
11 59.0 s 58.1 s 58.4 s 58.2 s 58.3 s 58.4 s 
12 73.1 d 73.0 d 72.8 d 72.7 d 73.1 d 73.2 d 
13 28.5 t 66.4 d 66.4 d 66.3 d 66.4 d 66.4 d 
14 73.6 d 73.8 d 73.7 d 73.8 d 73.5 d 73.8 d 
15 14.0 q 14.3 q 14.5 q 14.4 q 14.5 q 14.5 q 
16 72.3 t 44.5 t 63.9 t 63.8 t 63.8 t 62.7 t 
17 44.2 d 44.0 d 44.1 d 44.1 d 44.1 d 44.1 d 
18 175.6 s 174.9 s 175.2 s 175.2 s 175.1 s 175.2 s 
19 6.3 q 6.3 q 6.3 q 6.3 q 6.3 q 6.3 q 
20 49.0 t 48.9 t 49.0 t 49.1 t 49.1 t 48.8 t 
9-OAc 170.2 s 170.1 s 170.2 s 170.2 s 170.2 s 170.2 s 
 21.5 q 21.5 q 21.6 q 21.6 q 21.1 q 21.5 q 
R1 169.2 s 172.2 s 170.9 s 172.9 s 172.4 s 166.6 s 
 21.1 q 61.1 t 20.5 q 61.2 t 61.3 t 60.9 t 
      172.4 s 
      42.7 t 
      25.6 d 
      22.4 q (×2) 
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Table 1. Cont. 
R2 170.0 s 169.6 s see 1′–5′ see 1′–5′ 169.8 s 169.7 s 
 21.1 q 20.9 q   21.6 q 20.7 q 
R3 n.o. 169.7 s 169.7 s 169.7 s 169.7 s see 1′–5′ 
  20.5 q 21.5 q 20.5 q 20.6 q  
R4 169.8 s 170.6 s 170.1 s 170.7 s see 1′–5′ 170.5 s 
 21.1 q 20.9 q 20.8 q 20.9 q  20.7 q 
R5 58.4 q     see 1″–5″ 
1′   172.0 s 171.9 s 172.9 s 171.7 s 
2′   43.5 t 43.4 t 43.1 t 42.6 t 
3′   25.7 d 25.7 d 25.2 d 25.0 d 
4′   22.3 q (×2) 22.4 q (×2) 22.5 q 22.3 q (×2) 
5′     22.4 q  
1″      172.0 s 
2″      43.3 t 
3″      25.7 d 
4″ and 5″      22.4 q (×2) 
a 100 MHz, in CDCl3, assignments made by DEPT, HSQC, and HMBC. 
Table 2. 1H NMR data for gemmacolides N–S (1–6) a. 
Proton 1 2 3 4 5 6 
2 5.71 (d, 9.7) 5.65 (ov) 5.63 (ov) 5.76 (d, 9.4) 5.69 (d, 9.6) 5.69 (ov) 
3 5.60 (t, 10.5, 9.7) 5.64 (ov) 5.60 (ov) 5.63 (t, 9.4, 10.7) 5.63 (t, 9.6, 10.5) 5.63 (ov) 
4 6.27 (d, 10.5) 6.42 (d, 9.7) 6.35 (d, 9.6) 6.39 (d, 10.7) 6.39 (d, 10.5) 6.34 (d, 10.6) 
6 5.90 (d, 8.5) 6.07 (d, 9.0) 5.82 (d, 7.4) 5.86 (d, 8.9) 5.86 (d, 8.3) 5.69 (ov) 
7 5.01 (d, 8.5) 4.95 (d, 9.0) 4.96 (d, 7.4) 4.95 (d, 8.9) 4.95 (d, 8.3) 4.96 (d, 8.6) 
9 4.81 (br d, 4.6) 4.76 (br d, 4.5) 4.74 (br d, 4.8) 4.75 (br d, 4.5) 4.78 (br d, 4.7) 4.73 (br d, 4.9) 
10 3.69 (br d, 4.6) 3.62 (ov)  3.61 (br d, 4.8) 3.63 (ov) 3.62 (ov) 3.63 (ov) 
12 4.51 (ov) 4.88 (br d, 2.6) 4.92 (br d, 3.5) 4.93 (br d, 2.9) 4.90 (br d, 2.2) 4.88 (br s) 
13β 1.92 (ov) 5.06 (dd, 2.6, 2.6) 5.09 (dd, 3.5, 3.5) 5.08 (dd, 2.9, 3.9) 5.09 (dd, 2.2, 2.2) 5.09 (br s) 
13α 2.31 (ov)      
14 4.90 (br s) 5.17 (br d, 2.6) 5.23 (br d, 3.5) 5.19 (br d, 2.9) 5.24 (br d, 2.2) 5.20 (br s) 
15 1.04 (s) 1.14 (s) 1.14 (s) 1.15 (s) 1.15 (s) 1.13 (s) 
16a 4.48 (d, 15.2) 4.66 (d, 13.8) 4.51 (br s) 4.55 (d, 15.6) 4.54 (d, 15.0) 5.46 (d, 16.3) 
16b 4.24 (d, 15.2) 4.56 (d, 13.8)  4.45 (d, 15.6) 4.47 (d, 15.0) 4.56 (d, 16.3) 
17 2.32 (ov) 2.31 (q, 7.1) 2.30 (ov) 2.31 (ov) 2.31 (ov) 2.29 (ov) 
19 1.16 (d, 7.1) 1.15 (ov) 1.13 (d, 7.2) 1.14 (d, 7.2) 1.16 (ov) 1.14 (d, 6.9) 
20a 3.55 (br d, 2.4) 3.60 (ov) 3.63 (br d, 2.5) 3.62 (ov) 3.62 (br s) 3.61 (br s) 
20b 2.78 (br d, 2.4) 2.93 (br s) 2.93 (br d, 2.5) 2.94 (br s) 2.93 (br s) 2.93 (br s) 
9-OAc 2.19 (s) 2.19 (s) 2.19 (s) 2.20 (s) 2.19 (s) 2.18 (s) 
R1 1.96 (s) 4.15 (d, 16.9) 1.99 (s) 4.15 (d, 17.2) 4.16 (d, 16.4) 4.52 (d, 15.5) 
  4.03 (d, 16.9)  4.04 (d, 17.2) 4.03 (d, 16.4) 4.42 (d, 15.5) 
      2.28 (ov) 
      2.13 (ov) 
      0.97 (d, 6.5) (×2 Me)
R2 2.10 (s) 2.16 (s) see 2′–5′ see 2′–5′ 2.17 (s) 2.16 (s) 
R3 n.o. 1.95 (s) 1.94 (s) 1.94 (s) 1.94 (s) see 2′–5′ 
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Table 2. Cont. 
R4 2.02 (s) 2.09 (s) 2.09 (s) 2.11 (s) see 2′–5′ 2.10 (s) 
R5 3.45 (s)     see 2″–5″ 
2′a   2.35 (ov) 2.34 (m) 2.31 (m) 2.08 (ov) (×2) 
2′b   2.27 (ov) 2.23 (m) 2.20 (m)  
3′   2.17 (m) 2.16 (m) 2.05 (m) 1.99 (m) 
4′   0.99 (d, 6.3) 0.99 (d, 6.5) 0.98 (d, 7.1) 0.92 (d, 6.5) (×2 Me)
5′   1.01 (d, 6.3) 1.01 (d, 6.5) 1.00 (d, 7.1)  
2″      2.28 (ov) 
3″      2.13 (ov) 
4″ and 5″      0.98 (d, 6.1) (×2 Me)
a 400 MHz, in CDCl3, assignments made by 1H-1H COSY, HSQC, HMBC and NOESY. 
Figure 1. Key HMBC (arrow H→C) and COSY (bond) spin coupling systems for compound 1. 
 
Figure 2. Key NOESY correlations for compound 1. 
 
The absolute configuration of 1 was determined by TDDFT ECD calculation of the solution 
conformers. Although gemmacolide N (1) has zero specific rotation in chloroform, it showed a distinct 
solution ECD spectrum with a negative ECD transition in the region 250–200 nm and a positive band 
below 200 nm, which derives from the lactone and diene chromophores. The MMFF conformational 
search of 1 followed by B3LYP/6-31G(d) optimization provided four slightly different conformers 
(43.4%, 17.4% 14.8% and 13.1% populations, see Figure 3 and Supporting Information, Figure S1) 
above the population of 5%. They differed in the orientation of the methoxymethyl and C-12 acetoxy 
groups and only slightly in the conformation of the skeleton. It is also noteworthy that the C-12 and C-14 
acetoxy groups of 1 adopted the usually unfavorable near syn-antiperiplanar conformation for the methine 
proton and the carbonyl oxygen in all the conformers (projection angles ω12H,12C,C=O,C=O = 160.7°, 
ω14H,14C,C=O,C=O = 163.8° in the lowest-energy conformer). In contrast, the 2- and 9-acetoxy groups of 1 
have the expected near syn-coplanar conformation for the methine proton and the carbonyl oxygen 
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(projection angles ω2H,2C,C=O,C=O = 12.1°, ω9H,9C,C=O,C=O = −12.4° in the lowest-energy conformer). The 
unexpected conformation of the ester groups in 1 is due to steric crowding, which may lead to 
erroneous configurational assignment by the Mosher’s MTPA or MPA ester NMR method when not 
supported by a careful conformational analysis. The interatomic distances observed in the calculated 
conformers corroborated well the observed NOE effects and thus the relative configuration (Figure 2). 
The 2-OAc group has pseudoequatorial and 9-OAc pseudoaxial orientation in agreement with the 
measured coupling constants of H-2 (J = 9.7 Hz) and H-9 (J = 4.6 Hz). The 8-OH was hydrogen-bonded 
to the epoxide oxygen. The ECD spectra were then calculated for the four conformers with three 
different functionals (B3LYP, BH&HLYP, PBE0) and 6-311G(d,p) basis set. The four conformers 
gave nearly identical ECDs and the three functionals consistently reproduced the experimental ECD with 
BH&HLYP showing the best agreement (Figure 4). Since the Boltzmann-weighted BH&HLYP/ 
6-311G(d,p) ECD spectrum calculated for the (1R,2S,7S,8S,9S,10S,11R,12R,14S,17R)-enantiomer 
gave a good agreement with the experimental solution ECD, the absolute configuration of 
gemmacolide N (1) was unambiguously determined as identical to the calculated value. 
Figure 3. Structure of the lowest-energy conformer (43.4% population) of the 
(1R,2S,7S,8S,9S,10S,11R,12R,14S,17R)-enantiomer of 1. 
 
Figure 4. Experimental solution ECD spectrum of gemmacolide N (1) compared with the 
Boltzmann-weighted BH&HLYP/6-311G(d,p) ECD spectrum calculated for four 
conformational isomers of the (1R,2S,7S,8S,9S,10S,11R,12R,14S,17R)-enantiomer of 1. 
Bars represent the rotational strength of the lowest-energy conformers with the 
BH&HLYP/6-311G(d,p) method. 
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Comparison of the 1H and 13C NMR spectra of gemmacolides O–S (2–6) with those of 1 
immediately revealed that they are 11,20-epoxy-3,5-diene-type briarane analogues. Their structural 
determinations were aided by comparison of their spectra with those of 1. However, detailed NMR 
studies (including HSQC, HMBC, 1H-1H COSY and NOESY spectra) on each new compound were 
performed in order to unambiguously determine their structures and to assign all the proton and carbon 
resonances. As the briarane derivatives 2–10 contained the same lactone and diene chromophores as 
gemmacolide N (1) and they differed only in the nature of the ester groups and R5, the ECD spectrum 
of gemmacolide N (1) could be used as an ECD reference for the configurational assignment of 
derivatives 2–10. 
Gemmacolide O (2), a white amorphous powder (1.4 mg), had a molecular formula of C30H37O15Cl 
as established by HRESI-MS. An isotopic ratio of 3:1 observed in the molecular ion peak at 
m/z 695/697 ([M + Na]+) confirmed the appearance of a chlorine atom in the molecule, and the 1H and 
13C NMR spectra data (Tables 1 and 2) of 2 resembled those of 7. The C-2 glycoloyl group of 2 
(δH 4.15, d, J = 16.9 Hz and 4.03, d, J = 16.9 Hz; δC 172.2, s, 61.1, t) was distinct from the analogously 
positioned acetoxy group of 7 (δH 1.96, s; δC 168.7, s and 21.3, q). In addition, the upfield-shifted C-16 
signal of 2 (δC 44.5) in the 13C-NMR spectrum compared to that of 7 (δC 72.2) together with the 
absence of the methoxy group (δH 3.46, δC 58.5) indicated the position of a chlorine atom at C-16 [32]. 
The location of the glycoloyl group at C-2 was confirmed by the HMBC correlations of both H-2′ and 
H-2 with C-1′. The relative configuration of 2 was also proved the same as that of 7 by a NOESY 
experiment. Similarly to gemmacolide N (1), gemmacolide O (2) gave a negative ECD band at 202 nm 
and a positive one below 200 nm (Figure 5) and thus its absolute configuration was determined as  
(−)-(1S,2S,3Z,5E,7S,8S,9S,10S,11R,12R,13R,14R,17R) by its ECD spectrum. 
Figure 5. ECD spectra of gemmacolides O–S (2–6) in acetonitrile. 
 
Gemmacolide P (3) was obtained as a white amorphous powder (1.7 mg). Its HRESI-MS 
demonstrated the same molecular formula as C33H44O15 by HRESI-MS. 1H and 13C NMR 
spectroscopic data of 3 were almost identical to those of 10 except for the absence of the  
signals of the oxygenated methyl group (δH 3.45, s; δC 58.5, q). This fact suggested a primary  
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hydroxyl group at C-16 in 3. Detailed analysis of 1H-1H COSY and HMBC spectra clarified the  
isovaleryl group attached to C-12 in 3. The structure of 3 was thus determined as  
(−)-(1S,2S,3Z,5E,7S,8S,9S,10S,11R,12R,13R,14R,17R) based on the ECD spectrum (Figure 5). 
Gemmacolide Q (4) was isolated as a white amorphous powder (2.0 mg) and found to have a 
molecular formula of C33H44O16 established by HRESI-MS. 1H and 13C NMR spectra of 4 were similar 
to those of compound 3 but one of the acetyl groups in 3 was replaced by a glycoloyl group in 4. This 
hydroxylated acetyl group was attached at C-2 as supported by the HMBC correlations of H-2′ and  
H-2 with C-1′. The relative and absolute configuration of 4 was shown to be the same as that of 3 by 
the analysis of NOESY and ECD spectra (Figure 5). 
Gemmacolide R (5), a white amorphous powder (1.4 mg), showed the same molecular formula of 
C33H44O16 as that of 4 as deduced from its HRESI-MS. 1H and 13C NMR spectroscopic data of 5 were 
almost identical to those of 4 (Tables 1 and 2), showing the same functional groups for both 
compounds. The isovaleryl group, however, was found to be attached to C-14 of 5 instead of C-12 
based on the analysis of HMBC spectra. The structure of 5 had the same relative and absolute 
stereochemistry as that of 4 assessed by the NOESY and ECD measurements (Figure 5). 
Gemmacolide S (6) was obtained as a white amorphous powder (2.1 mg) with a molecular formula 
of C43H60O18 as established by HRESI-MS. Comparison of overall 1H and 13C NMR data of 6 and 
those of 2 revealed similarities (Tables 1 and 2). However, the primary alcohol of the glycoloyl group 
in 2 was further isovalerylated in 6 while the two acetyl groups at C-12 and C-14 remained intact due 
to the obvious HMBC correlations from the secondary alcohol protons to the respective ester carbonyl 
groups. The presence of two isovaleryl groups were assigned at C-13 and C-16 by the HMBC 
correlations from H-13 and H2-16 to the carbonyl atom of both isovaleryl groups [δC 171.7 (s),  
172.0 (s)], respectively. The relative and absolute configuration of all the chiral centers was found the 
same as that of 2 by the NOESY and ECD analysis (Figure 5). 
In briarane-type diterpenoids, the flexible bicyclo[8.4.0]tetradecane skeleton [3] and the complexity 
due to substitution pattern lead a great challenge in the stereochemical studies of the chiral centers. In 
this paper, the absolute configuration of 1 was solved by a TDDFT calculation of the solution ECD 
spectrum. The measured negative ECD band at about 215 nm and the positive one below 200 nm were 
correlated with (1S,2S,7S,8S,9S,10S,11R,12R,13R,14R,17R) absolute configuration as proved by 
TDDFT ECD calculations. The example of gemmacolide N (1) serves as a reference for the 
configurational assignment of related compounds considering the similar ECD curves (Figures 5 
and 6) recorded for the new analogues 2–6 and the known compounds 7–10 (Figures 5 and 6), 
respectively. The research work may hold as a basis for the determination of absolute configuration for 
such complex marine natural products using an ECD method. 
The cytotoxic activity and antimicrobial activity of compounds 1–10 were evaluated. In in vitro 
bioassays, compounds 4, 5, 6, 8 and 9 showed cytotoxicity against human lung adenocarcinoma cells 
(A549) and human osteosarcoma cell (MG63). Compound 7 showed cytotoxicity against A549 and no 
activity toward MG63. Compounds 1, 3, and 10 showed no cytotoxic activity toward A549 and MG63 
at 50.5, 44.1 and 43.2 μM, respectively (Table 3). Compounds 1, 4, 7–10 exhibited weak antifungal 
activity against Septoria tritici while compounds 1, 2, 4, 7–10 showed potential antibacterial activity 
against the Gram negative bacterium Escherichia coli. None of the compounds were active toward the 
fungus Microbotryum violaceum and the Gram positive bacterium Bacillus megaterium (Table 4). 
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Figure 6. ECD spectra of juncnolide D, juncins R, S and U (7–10) in acetonitrile. 
 
Table 3. Cytotoxicity of compounds 1–10 against two tumor cell lines in vitro (IC50 in μM). 
 1 2 3 4 5 6 7 8 9 10 Adriamycin a
A549 >50.5 >44.6 >44.1 21.6 ± 1.8 27.2 ± 2.4 16.4 ± 2.3 37.1 ± 4.2 13.9 ± 2.5 20.2 ± 2.3 >43.2 2.8 ± 0.32 
MG63 >50.5 >44.6 >44.1 20.5 ± 2.1 23.7 ± 2.8 18.8 ± 3.9 >46.0 5.6 ± 1.2 16.5 ± 2.4 >43.2 3.2 ± 0.37 
Results are presented as mean ± s.d. (n = 3). a Positive control. 
Table 4. Agar diffusion assays for antibacterial, and antifungal activities a,b. 
 M. violaceum S. tritici E. coli B. megaterium 
1 0 7.5 12.5 0 
2 6.0 6.5 13.0 6.0 
3 6.0 6.5 7.5 5.5 
4 6.5 7.5 10.0 5.5 
5 0 5.5 5.5 6.0 
6 7.0 0 6.0 0 
7 6.0 7.5 12.5 6.0 
8 7.5 7.5 14.0 6.0 
9 5.5 7.0 10.0 0 
10 0 7.5 11.0 8.0 
penicillin 7.0 6.0 15.0 8.0 
streptomycin 8.0 5.5 9.0 5.5 
ketoconazole 15.0 12.5 9.0 11.0 
acetone 0 0 0 0 
a 0.05 mg of the test or control substances dissolved in acetone were applied to a filter disc and 
sprayed with the respective test organism. b Radii of the zones of inhibition are given in mm. 
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3. Experimental Section 
3.1. General Experimental Procedures 
Commercial silicagel (Yantai, China, 200–300; 400–500 mesh) and RP silicagel (Merck, Germany, 
43–60 μm) were used for column chromatography (CC). Precoated silicagel plates (Yantai, China, 
HSGF-254) and RP silicagel (Macherey-Nagel, Germany, RP-18 F254) were used for analytical  
thin-layer chromatography (TLC). Spots were detected on TLC under UV or by heating after spraying 
with anisaldehyde-sulphuric acid reagent. The NMR spectra were recorded at 300 K on a Bruker drx 
400 spectrometer. Chemical shifts are reported in parts per million (δ), with use of the residual CHCl3 
signal (δH 7.26 ppm) as an internal standard for 1H NMR and CDCl3 (δC 77.0 ppm) for 13C NMR; 
Coupling constants (J) are reported in Hz. 1H NMR and 13C NMR assignments were complemented 
1H-1H COSY, HSQC, HMBC and NOESY experiments. The following abbreviations are used to 
describe spin multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br s = broad 
singlet, dd = doublet of doublets, ov = overlaped signals. Optical rotations were measured in CHCl3 
with an Autopol IV polarimeter at the sodium D line (590 nm). Infrared spectra were recorded in thin 
polymer films on a Nexus 470 FT-IR spectrophotometer (Nicolet, USA); peaks are reported in cm−1. 
UV absorption spectra were recorded on a Varian Cary 100 UV-Vis spectrophotometer; peaks 
wavelengths are reported in nm. Circular dichroism spectra were recorded with a JASCO J-715 
circular dichroism spectropolarimeter. The MS and HRMS were performed on a Q-TOF Micro mass 
spectrometer, resolution 5000. An isopropyl alcohol solution of sodium iodide (2 mg/mL) was used as 
a reference compound. Semi-preparative RP-HPLC was performed on an Agilent 1100 system 
equipped with a refractive index detector using an YMC Pack ODS-A column (particle size 5 μm,  
250 × 10 mm). 
3.2. Animal Material 
The gorgonian coral Dichotella gemmacea (3.5 kg, wet weight) was collected from the South China 
Sea, in August 2007 and identified by Dr. Xiu-Bao Li, the South China Sea Institute of Oceanology, 
Academia Sinica. A voucher specimen was deposited in the Second Military Medical University, 
Shanghai, China. 
3.3. Extraction and Isolation 
The frozen specimen was extracted with acetone and methanol (3 × 1.5 L) by ultrasonication. The 
solvent was combined and removed in vacuo. The resultant residue was partitioned between H2O and 
EtOAc. The layers were separated, and then EtOAc was removed to afford 16.1 g of residue. The 
crude extract was further partitioned between MeOH and hexane, affording 11.2 g from the MeOH 
fraction. This residue was subjected to silica gel CC and eluted with hexane/acetone (from 100:0 to 
0:100) as eluent. Fraction 13 was further fractionated by RP-silical gel CC (MeOH/H2O, 23:77 to 
67:33, in 5% increments) to give three subfractions (A–C). Subfraction A was purified by HPLC 
(MeOH/H2O, 60:40, 1.5 mL min−1) to yield 1 (1.1 mg, 25.6 min) and 7 (2.1 mg, 28.7 min). Fraction 12 
was further fractionated by silicagel CC (n-hexane/acetone, 80:20 to 50:50, in 2.5% increments) to 
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give three subfractions (A–C). Subfraction A was purified by HPLC (MeOH/H2O, 65:35,  
1.5 mL min−1), yielding 3 (1.7 mg, 37.5 min). Fraction 9 was purified by HPLC (MeOH/H2O, 67:33, 
1.5 mL min−1) to give 2 (1.4 mg, 27.2 min), 5 (1.4 mg, 30.2 min) and 4 (2.0 mg, 32.1 min). Fraction 8 
and 7 were repeatedly subjected to silicagel and Sephadex LH-20 CC, and then purified by HPLC 
(MeOH/H2O, 70:30, 1.5 mL min−1) to yield 8 (3.3 mg, 29.7 min), 9 (3.1 mg, 32.3 min), 10 (3.1 mg, 
43.9 min). Fraction 4 was further fractionated by RP-silical gel CC (gradient elution from MeOH/H2O, 
3:7 to MeOH, in 5% increments) and purified by HPLC (MeOH/H2O, 80:20, 1.5 mL min−1), yielding 6 
(2.1 mg, 38.7 min). 
Gemmacolide N (1): white amorphous powder; [α]24 D  = 0 (c 0.035, CHCl3); UV (MeOH) 207, 
273 nm; CD (CH3CN, c 4.2 × 10−4) λmax (Δε) positive below 200 nm, 205 (−1.45), 223 (−1.35) nm;  
IR (film) νmax 3475, 1776, 1739 cm−1; 1H NMR spectroscopic data, see Table 2; 13C NMR 
spectroscopic data, see Table 1; ESI-MS m/z 617 [M + Na]+; HRESI-MS m/z 617.2213 [M + Na]+ 
(calcd for C29H38O13Na, 617.2210). 
Gemmacolide O (2): white amorphous powder; [α]24 D  = −30 (c 0.04, CHCl3); UV (MeOH) 206 nm; 
CD (CH3CN, c 4.3 × 10−4) λmax (Δε) positive below 193 nm, 202 (−6.47) nm; IR (film) νmax 3469, 1776, 
1742 cm−1; 1H NMR spectroscopic data, see Table 2; 13C NMR spectroscopic data, see Table 1; ESI-MS 
m/z 695 [M + Na]+; HRESI-MS m/z 695.1721 [M + Na]+ (calcd for C30H37O15ClNa, 695.1719). 
Gemmacolide P (3): white amorphous powder; [α]24 D  = −16 (c 0.08, CHCl3); UV (MeOH) 204 nm; 
CD (CH3CN, c 1.2 × 10−4) λmax (Δε) positive below 200 nm, 216.5 (−12.77) nm; IR (film) νmax 3479, 
1775, 1743 cm−1; 1H NMR spectroscopic data, see Table 2; 13C NMR spectroscopic data, see Table 1; 
ESI-MS m/z 703 [M + Na]+; HRESI-MS m/z 703.2580 [M + Na]+ (calcd for C33H44O15Na, 703.2578). 
Gemmacolide Q (4): white amorphous powder; [α]24 D  = −17 (c 0.065, CHCl3); UV (MeOH) 204 nm; 
CD (CH3CN, c 7.2 × 10−4) λmax (Δε) positive below 199 nm, 217.5 (−4.22) nm; IR (film) νmax 3456, 
1772, 1742 cm−1; 1H NMR spectroscopic data, see Table 2; 13C NMR spectroscopic data, see Table 1; 
ESI-MS m/z 719 [M + Na]+; HRESI-MS m/z 719.2533 [M + Na]+ (calcd for C33H44O16Na, 719.2527). 
Gemmacolide R (5): white amorphous powder; [α]24 D  = −18 (c 0.05, CHCl3); UV (MeOH) 204 nm; 
CD (CH3CN, c 3.3 × 10−4) λmax (Δε) positive below 197 nm, 200.5 (−7.46) nm; IR (film) νmax 3476, 
1772, 1741 cm−1; 1H NMR spectroscopic data, see Table 2; 13C NMR spectroscopic data, see Table 1; 
ESI-MS m/z 719 [M + Na]+; HRESI-MS m/z 719.2529 [M + Na]+ (calcd for C33H44O16Na, 719.2527). 
Gemmacolide S (6): white amorphous powder; [α]24 D  = −71 (c 0.055, CHCl3); UV (MeOH) 206 nm; 
CD (CH3CN, c 1.4 × 10−4) λmax (Δε) positive below 191 nm, 197.5 (−15.11) nm; IR (film) νmax 3478, 
1778, 1744 cm−1; 1H NMR spectroscopic data, see Table 2; 13C NMR spectroscopic data, see Table 1; 
ESI-MS m/z 887 [M + Na]+; HRESI-MS m/z 887.3676 [M + Na]+ (calcd for C43H60O18Na, 887.3677). 
Juncenolide D (7): white amorphous powder; [α]24 D  = −11 (c 0.10, CHCl3); CD (CH3CN, c 1.9 × 10−4) 
λmax (Δε) positive below 200 nm, 214 (−6.26) nm. 
Juncin R (8): white amorphous powder; [α]24 D  = −37 (c 1.14, CHCl3); CD (CH3CN, c 3.6 × 10−4) 
λmax (Δε) 198 (−10.51) nm. 
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Juncin S (9): white amorphous powder; [α]24 D  = −33 (c 0.97, CHCl3); CD (CH3CN, c 1.8 × 10−4) 
λmax (Δε) positive below 192 nm, 202 (−10.46) nm. 
Juncin U (10): white amorphous powder; [α]24 D  = −20 (c 0.87, CHCl3); CD (CH3CN, c 1.8 × 10−4) 
λmax (Δε) positive below 198 nm, 214 (−5.89) nm. 
3.4. Computational Section 
Mixed torsional/low mode conformational searches were carried out by means of the Macromodel 
9.7.211 [33] software using Merck Molecular Force Field (MMFF) with implicit solvent model for 
chloroform. The MMFF analysis provided seventy two conformers in an 11 kJ/mol energy window, 
which were then reoptimized at the B3LYP/6-31G (d) level of theory affording four conformers. This 
was followed by TDDFT ECD calculations using various functionals (B3LYP, BH&HLYP, PBE0) 
and 6-311G (d,p) basis set implemented in the Gaussian 03 [34] package. Boltzmann distributions 
were estimated from the ZPVE corrected B3LYP/6-31G (d) energies of the optimized conformer 
geometries obtained at the same level of theory in the gas-phase calculations. ECD spectra were 
generated as the sum of Gaussians [35] with 3000 cm−1 half-height width (corresponding to ca. 15 nm 
at 220 nm), using dipole-velocity computed rotational strengths. The MOLEKEL [36] software 
package was used for visualization of the results. 
3.5. Cytotoxicity Assay 
Compounds 1–10 were evaluated for cytotoxicity against human lung adenocarcinoma (A549) and 
human osteosarcoma cell (MG63), using a modification of the 3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide (MTT) colorimetric method [37]. Adriamycin was used as 
positive control. 
3.6. Agar Diffusion Test for Biological Activity 
Compounds 1–10 were dissolved in acetone at 2 mg/mL; 25 μL of the solution (0.05 mg) were 
pipetted onto a sterile filter disc (Schleicher & Schuell, 9 mm), which was placed onto an appropriate 
agar growth medium for the respective test organism and subsequently sprayed with a suspension of 
the test organisms. The test organisms were bacteria, gram-negative bacterium Escherichia coli and  
the gram positive bacterium Bacillus megaterium (both grown on NB medium), and fungi, 
Microbotryum violaceum and Septoria tritici (both grown on MPY medium). Reference substances 
were ketoconazole, penicillin and streptomycin. The radius of the zone of inhibition was measured in 
mm. These microorganisms were chosen because (a) they are non-pathogenic and (b) had in the past 
proved to be accurate initial test organisms for antibacterial and antifungal activities (each 0.05 mg). 
Commencing at the outer edge of the filter disc, the radius of the zone of inhibition was measured  
in mm. 
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